• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS COAGUCHEK ® XS SYSTEM; PROTHROMBIN TIME TEST STRIPS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS COAGUCHEK ® XS SYSTEM; PROTHROMBIN TIME TEST STRIPS Back to Search Results
Catalog Number 04625374160
Device Problem Incorrect Or Inadequate Test Results (2456)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 03/21/2018
Event Type  malfunction  
Manufacturer Narrative
Unique identifier (udi)#: (b)(4).
 
Event Description
The patient stated that he received erroneous results when testing with coaguchek xs meter serial number (b)(4).Two test strips lot numbers were used for testing, lots 25863822 and 24789623.Patient identifiers for information related to each test strip lot number: pt-22284 = test strip lot number 24789623, pt-22285 = test strip lot number 25863822.At 3:20 p.M., the patient tested a sample on the meter using test strip lot number 24789623 and the result was 4.1 inr.At 3:30 p.M., the patient tested a sample on the meter using test strip lot number 24789623 and the result was 3.1 inr.At 3:40 p.M., the patient tested a sample on the meter using test strip lot number 25863822 and the result was 3.5 inr.The patient mentioned that he collected samples from his little finger for 2 of the tests.No adverse events were alleged to have occurred with the patient.No treatment was provided to the patient based on the meter results.The patient's therapeutic range is 2.0 - 3.0 inr.The patient's testing frequency is every 2 weeks.The patient does not have anemia or antiphospholipid antibodies.The patient does not take heparin or direct thrombin inhibitors.The patient has had no changes in his coumadin dosage or diet.The patient did not have any special or unusual diet.The patient has had no new medications or illnesses.The patient did not have signs of bleeding or bruising.The patient's meter had not been cleaned.The patient did not recall if internal controls on the meter passed.The patient's product was requested for investigation and replacement product was sent to the patient.Relevant retention test strips (lot 247896-23) were tested in comparison with the current master lot coaguchek xs pt test strip.For this purpose two human blood samples from marcumar donors and two internal reference meters were used.No error messages occurred.Retention samples were within specifications.
 
Manufacturer Narrative
The customer's meter was returned for investigation.The returned meter and masterlot strips were tested in comparison to a retention meter and masterlot strips.Human blood samples from warfarin donors were used.Donor 1 inr: 2.0 inr, donor 2 inr: 2.8 inr.Donor 1 hct: 45%, donor 2 hct: 48%.Testing results: donor 1: retention meter with masterlot strips: 2.0 inr, customer meter with masterlot strips: 2.0 inr.Donor 2: retention meter with masterlot strips: 2.8 inr, customer meter with masterlot strips: 2.9 inr.Results: all inr values were within the specified maximum difference between measurements.No error messages occurred.The returned and the retention material meet the specifications.The customer stated they used the same finger for two tests.Per package insert, for a second measurement a new puncture of a different finger is mandatory.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COAGUCHEK ® XS SYSTEM
Type of Device
PROTHROMBIN TIME TEST STRIPS
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key7400128
MDR Text Key105451620
Report Number1823260-2018-01070
Device Sequence Number1
Product Code GJS
Combination Product (y/n)N
PMA/PMN Number
K062925
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Type of Report Initial,Followup
Report Date 04/26/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/05/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date01/31/2019
Device Catalogue Number04625374160
Device Lot Number24789623
Was Device Available for Evaluation? No
Date Manufacturer Received03/21/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
FLUOXETINE; LASIX; TERAZOSIN; TOPAROL; WARFARIN/COUMADIN
Patient Age64 YR
-
-